Finding out you have a kidney tumor can be frightening. Most patients automatically think surgery is the only answer — and that’s understandable. But in reality, the biology of kidney tumors varies widely.
Not every tumor behaves aggressively. Not every tumor needs immediate surgery. And knowing the difference can spare you unnecessary treatment without compromising long-term health.
At her practice, Dr. Shirin Razdan sees patients every week who are relieved to learn this:
A kidney mass doesn’t always need to be removed right away.
What matters is understanding which tumors are truly dangerous, how they are monitored, and when surgery genuinely becomes necessary.
Kidney Tumors Aren’t All the Same
A kidney tumor is simply an abnormal growth in the kidney. It can be:
- A benign (non-cancerous) mass
- A very slow-growing cancer
- A more aggressive cancer in need of surgery
The first key point Dr. Razdan makes to every patient is this:
The number on your imaging report doesn’t tell the whole story.
How the tumor behaves over time and what imaging shows about its characteristics matter far more than size alone.
When We Watch — Instead of Operate
There are clear, evidence-based situations where immediate surgery may not be necessary. At these times, Dr. Razdan often recommends active surveillance — careful, repeat imaging and monitoring instead of going straight to the operating room.
This is most often appropriate when:
1. The Tumor Is Small
Tumors under 3 cm are frequently slow-growing and may never cause problems in some patients, especially older adults with other health conditions.
2. The Growth Pattern Is Slow
Dr. Razdan compares serial imaging over time. If a mass hasn’t changed in size over months or years, that stability suggests a less aggressive process.
3. A Patient Has Other Serious Health Conditions
For some patients, surgery carries more risk than the tumor itself. Heart disease, severe lung disease, or other major health issues can tip the scale toward monitoring instead of immediate surgery.
4. Biopsy or Imaging Suggests Low Risk
In selected cases, biopsy combined with MRI characteristics suggests a low-grade tumor that can safely be observed.
In these cases, surveillance is intentional — not passive.
It means scheduled follow-up scans, labs, and check-ins to make sure nothing changes.
Dr. Razdan doesn’t leave it to chance — she uses a structured monitoring plan that’s individualized for each patient.
Why Immediate Surgery Isn’t Always Better
Many patients have the instinct that “taking it out now is safer,” but this isn’t always supported by evidence.
Dr. Razdan explains:
- Surgery carries real risks, including bleeding, infection, and impact on kidney function.
- Partial nephrectomy (removing only the tumor) preserves more kidney tissue — but it is still an operation.
- Some small tumors grow so slowly that surgery may offer no meaningful benefit over years of monitoring.
The goal isn’t to avoid surgery — it’s to make sure surgery is timely, safe, and truly necessary.
What Active Surveillance Looks Like With Dr. Razdan
Unlike passive “watch and wait,” active surveillance is structured:
- Regular imaging, typically every 3–6 months initially
- Periodic lab testing, including kidney function
- Clear criteria for when surveillance should transition to intervention
- Discussion of individual risk factors based on age, genetics, and other health conditions
Patients often tell Dr. Razdan that this approach gives them clarity and control — not uncertainty. They understand the plan, the schedule, and the thresholds for action.
When Surveillance Changes to Surgery
Surveillance isn’t indefinite. It’s a decision framework that changes based on real evidence.
Surgery becomes recommended when:
- Tumor size increases significantly
- New symptoms develop
- Imaging suggests more aggressive features
- Patient preference shifts after understanding risk
The transition isn’t abrupt. It’s based on objective changes — not fear.
Why Experience Matters
Interpreting kidney tumors isn’t a “one number on a scan” decision. It requires context, judgment, and pattern recognition — which is where Dr. Razdan’s experience makes a difference.
Dr. Shirin Razdan has spent years evaluating kidney tumors & of all kinds. She has seen patients with small masses live for a decade with no progression, and she has also identified patterns where early surgery was the safer choice.
Her guidance isn’t based on rules alone — it’s based on understanding how tumors behave in real patients, not textbooks.
Frequently Asked Questions
Is a small kidney tumor complex always cancerous?
No. Many small tumors are benign or slow-growing cancers that may never cause harm.
If surgery isn’t done immediately, is there a risk of missing cancer?
Active surveillance includes frequent imaging and labs specifically to catch changes early if they occur.
How often will I need scans during surveillance?
Typically, every 3–6 months at first, then possibly less often if stability is demonstrated.
Can I switch from surveillance to surgery later?
Yes. Decisions are ongoing and based on changes in size or characteristics.
Does surveillance hurt kidney function?
No. Surveillance itself doesn’t impact kidney function. Surgery — especially partial nephrectomy — carries more impact on kidney tissue.
Contact Dr. Shirin Razdan
If you’ve been told you have a kidney tumor and are unsure whether surgery is necessary, a consultation with Dr. Shirin Razdan provides clarity and a personalized plan.
Dr. Razdan focuses on thoughtful risk assessment, evidence-based decision-making, and patient priorities — not one-size-fits-all recommendations.
📍 Miami Robotic Surgery — Shirin Razdan, MD
🌐 Website: https://miamiroboticsurgery.com
📞 Phone:305-468-3314
Related posts:
Dr. Shirin Razdan Featured on SurvivorNet – Breaking Down Prostate Cancer Facts, Myths, and Treatment Options
Is Kidney Cancer Hereditary? Understanding Genetic Risk
Kidney Cancer Symptoms in Females vs. Males: What’s Different?
Partial vs. Radical Nephrectomy: How Surgeons Decide What You Actually Need